Home
About Us
Company Profile
HIstory
Culture
Honor
Products
Cardiovascular series
Psychiatry series
Hepatobiliary, Gastroenterology Series
Respiratory series
Anti-infective virus series
Other series
Large Infusion Series
Huabao Tong Series
Active Pharmaceutical Ingredient Series
R&D
Academician Expert Workstation
Medical Research and Industry Alliance
News
General News
Party group dynamics
Employee activity
HR
Talent Strategy
Company recruitment
Contact us
中文版
Date:
29 Aug,2022
5 Month, Acquiring Tangshan Bohai Pharmaceutical Co., Ltd.
Previous page
2009
2004
Next page
Related Recommendations
2023/11/07
Standardized Development of MAH Pharmacovigilance System | The 19th Taizhou Pharmaceutical Regulatory Salon Event Successfully Held at Wanbangde
2023/11/01
Pragmatic Action Drives Success, Striving for Excellence in Quality | Wanbangde Pharmaceutical Group’s 6th “Quality Month” QC Team Activity Concludes Successfully
2023/10/26
Good News | Wanbangde Pharmaceutical Group's QC Department 1 Wins the "Taizhou City Workers' Pioneer Award" Honor